Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
One in every hundred adults in the Western world suffers from chronic glaucoma, a disease that causes blindness. Prof. Michal Schwartz,...
Institute scientists halt progressive eyesight loss in animals afflicted with a glaucoma-like disease
Prof. Ephraim Katzir reminisces about the last 50 years of the Weizmann Institute
Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS